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Background: Histamine is an indicator of mast cell activation. N-methylhistamine (NMH) 
is a metabolite of histamine that can be measured in urine. 
Objective: Our purpose was to assess the usefulness of determining urinary NMH levels for 
the diagnosis and follow-up of patients with mastocytosis. 
Methods: Urinary NMH levels were determined in 44 patients and were correlated with dis- 
ease activity and extension. The control group consisted of 24 children without mastocytosis 
or any other skin disease. 
Results: A significant negative correlation was found between NMH and age in patients with 
active mastocytosis and in the control group. Adjusted for age, NMH values were significantly 
higher in patients with active mastocytosis. There was a significant difference in NMH val- 
ues between patients with diffuse cutaneous mastocytosis, patients with active urticaria pig- 
mentosa, and patients with active mastocytomas. However, there was a substantial overlap 
of NMH values in the different subgroups. 
Conclusion: Urinary NMH values tend to decrease with age. Urinary NMH values corre- 
lated with the extent and the activity of the disease. High NMH values suggest more exten- 
sive involvement. 
(J Am Acad Dermatol 1996;35:556-8.) 
Mastocytosis consists of an array of clinical and 
biochemical abnormalities that are a consequence of
tissue infiltration by an excess of mast cells and the 
release of various biologically active mediators from 
these cells. TM Patients with mastocytosis are usually 
classified according to the extent of the skin abnor- 
malities. Children with less than five distinct skin 
lesions are placed in the group of mastocytomas nd 
those with five or more lesions are classified as hav- 
ing urticaria pigrnentosa. The term diffuse cutaneous 
mastocytosis i used when the skin is diffusely 
involved. 
N-Methylhistamine (NMH) is a degradation prod- 
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Tab le  I. Distribution of the study patients in the 
different subgroups of mastocytosis 
Subgroup 
Active 
mastocytosis 
(No.) 
Nonactive 
mastocytosis 
(No.) 
Mastocytomas (n= 14) 12 2 
Urticaria pigmentosa (n= 27) 21 6 
Diffuse cutaneous 3 0 
mastocytosis (n= 3) 
Total patients with 36 8 
mastocytosis (n = 44) 
uct of histamine, one of the main excretion products 
of mast cells. An increased plasma level of histamine 
in patients with mastocytosis has been reported. 6'7 
However, measurement of plasma and urinary his- 
tamine levels appears to be less accurate than the 
measurement of the urinary NMH level, s,9 We in- 
vestigated the usefulness of urinary NMH in the di- 
agnosis and follow-up of children with mastocytosis. 
MATERIAL  AND METHODS 
Forty-four patients and 24 control subjects were en- 
rolled into this study. The patients' ages ranged from 2 
JournN of~eAmef ic~ AcademyofDermatology 
Volume35, Number4 Van Gysel et al. 557 
10000= 
¢1 
,Q 
t~ 
O 
A 
-E° loo0 , . 
o 
E 
t"  
'~ 100 
• "1- • 
Z • 
o 
10 , , , i , , , ~ , , i , , , i , , , i , , , i , , , i ,  , i , , , i  
0 2 4 6 8 10 12 14 16 18 
age (years) 
Fig. 1. NMH values (after log transformation) of all patients with active mastocytosis and 
of the controls, showing the decline with age. Upper line (,4) is regression line for patients 
with active mastocytosis; lower line (B) is regression line for control subjects. O, Active mas- 
tocytomas; O, diffuse cutaneous mastocytosis; A, active urticaria pigmentosa; &, controls. 
Tab le  I I .  Comparison of urinary NMH values in 
our control group with normal values according to 
Schulze et al.12 
Study control group Sehulze t al. 
<4 yr 272.3 (109-423) 213 (101-524) 
(n = 8) (n : 19) 
4-10 yr 225.2 (73-270) 181 (79-375) 
(n = 10) (n : 20) 
>10 yr 140.3 (36-267) 134 (50-247) 
(n = 6) (n = 18) 
Data expressed as mean (range given in parentheses) in micromoles of 
NMH per mole of creatinine. 
months to 17 years. The control group consisted of chil- 
dren without mastocytosis orany other skin disease. The 
age distribution of the control group was the same as that 
of the patient population. 
The patients were placed into subgroups according to 
the extent of their skin abnormalities. In addition, the ac- 
tivity of their disease was assessed by history (reports of 
conditions such as flushing) and clinical examination 
(Darier's ign). On the basis of these findings the groups 
were further subdivided of those children with active and 
inactive mastocytosis. 
The NMH levels in the urine samples were determined 
in duplicate with a double antibody radioimmunoassay 
(Pharmacia, Woerden, The Netherlands). The concentra- 
tions of NMH were expressed as micromoles of NMH per 
mole of creafinine in the urine. 
Statistical analyses were conducted by means of the 
Tab le  I I I .  Mean, median, and range of the 
urinary NMH values in the different subgroups 
Mean Median Range 
Mastocytosis (n = 44) 453 262 82-4182 
Active mastocytosis 516 288 132-4182 
(n = 36) 
Active mastocytoma(s) 318 257 171-1000 
(n = 12) 
Active urticaria 424 293 132-2320 
pigmentosa (n= 21) 
Diffuse cutaneous 1858 1054 338-4182 
mastocytosis (n= 3) 
Inactive mastocytosis 168 162 82-247 
(n = 8) 
Conlrol subjects (n = 24) 219 248 36-423 
Data expressed in micromoles ofNMH per mole of creafinine. 
Spearman rank correlation 1° and multiple regression 
analysis. 11 
RESULTS 
The distribution of the patients in the different 
subgroups with active and inactive disease is shown 
in Table I. This distribution is in agreement with the 
relative occurrence of the different forms of the dis- 
ease. 3
Systemic omplaints were present in one patient 
with mastocytoma, in one patient with urticaria pig- 
mentosa, and in all patients with diffuse cutaneous 
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mastocytosis. Contact urticaria induced by peanuts 
was present in one patient with active urticaria pig- 
mentosa. This patient also had severe atopic derma- 
titis. 
The values of NMH excreted in the urine samples 
from our control group were similar to the normal 
values found by Schulze et al.12 (Table II). 
Fig. 1 shows the decline of NMH (after log trans- 
formation) with age in the control group and in the 
group of patients with active mastocytosis. Mean, 
median, and range of the values of NMH excreted 
in the urine samples of the patients in different 
groups are shown in Table Ill. A substantial overlap 
between the concentrations of NMH in the different 
subtypes i  evident. 
A significant negative rank correlation was found 
between NMH and age in patients with active mas- 
tocytosis (rs = -0.452; p = 0.006; n = 36) as well as 
in the control subjects (rs =-0.510;p = 0.011;n = 24) 
(rs = Spearman rank correlation coefficient). 
With multiple regression analysis to adjust for 
age, a significant difference in NMH (after log 
transformation) was found between patients and 
control subjects. NMH values in patients were, on 
average, 70% higher than those of the control sub- 
jects (p = 0.0023). 
This average ffect (adjusted for age) can be fur- 
ther specified in the different subgroups of patients 
as follows: the NMH values in patients with active 
mastocytomas were 49% higher than in the control 
subjects (p = 0.032), 64% higher in patients with ac- 
tive urticaria pigmentosa (p =0.002), and 573% 
higher in patients with diffuse cutaneous mastocyto- 
sis than in the control subjects (p = 0.000). 
NMH decreased by 6.1% per year of age 
(p = 0.001); there was no evidence that this age ef- 
fect differed between the groups (p -- 0.338). 
DISCUSSION 
The results of this study showed that urinary 
NMH values, adjusted for age, were higher in chil- 
dren with active mastocytosis than in the age- 
matched control group. We found that he more ex- 
tensive the skin lesions, the higher the average val- 
ues of the urinary NMH and the more significant the 
difference between the control group and the re- 
spective subgroup of patients with active mastocy- 
tosis. Therefore high levels of NMH suggest more 
severe and extensive disease and possible systemic 
involvement. In systemic disease NMH levels can be 
useful to follow the evolution of mastocytosis. 
On the other hand, the distribution of NMH lev- 
els in the various ubgroups and in the control group 
substantially overlapped. In part this is a conse- 
quence of the age dependency of the NMH levels 
with higher (normal) values during early child- 
hood.12, 13 
We suggest that in childhood mastocytosis, mea- 
surement of the urinary NMH level may be useful at 
the time of diagnosis. It should only be repeated later 
in patients in whom the initial value was high or if 
new signs or symptoms, indicating activation of the 
mastocytosis, appear. 
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